期刊文献+

下调ANRIL对Kasumi-1细胞增殖和凋亡的影响及其相关作用机制研究

Effect of Down-Regulation of ANRIL on Proliferation and Apoptosis of Kasumi-1 Cells and Its Potential Mechanism
下载PDF
导出
摘要 目的:探讨下调ANRIL(Antisense non-coding RNA in the INK4 Locus)表达对Kasumi-1细胞增殖和凋亡的影响及其相关分子机制。方法:使用重组慢病毒构建下调ANRIL表达的Kasumi-1细胞(sh-ANRIL组)及其对照组细胞(sh-NC组),荧光显微镜观察慢病毒对细胞的转染效率,RT-qPCR检测敲低效率及急性髓细胞白血病(AML)患者外周血和骨髓中ANRIL的表达水平。CCK-8法和流式细胞术检测下调ANRIL表达对Kasumi-1细胞增殖和凋亡的影响。Western blot检测下调ANRIL表达后Kasumi-1细胞中PI3K、AKT、p-AKT等相关蛋白分子的表达。结果:ANRIL在AML患者外周血和骨髓中呈高表达;重组慢病毒对Kasumi-1细胞的转染效率>90%,敲低效率为70%;CCK-8结果显示,下调Kasumi-1细胞中ANRIL表达能够显著抑制细胞增殖,当DNR作用24、48、72 h,sh-ANRIL组的细胞增殖抑制率分别为(47.40±1.49)%、(69.11±0.51)%和(91.82±1.10)%,均显著高于sh-NC组(40.69±1.70)%(P<0.05)、(58.93±1.74)%(P<0.01)和(82.93±0.37)%(P<0.001);流式细胞术分析显示,sh-ANRIL组细胞凋亡率为(10.29±0.58)%,显著高于sh-NC组的(5.42±0.67)%(P<0.01),当DNR作用24 h,sh-ANRIL组细胞凋亡率为(54.41±1.69)%,显著高于sh-NC组的(38.28±1.42)%(P<0.001);Western blot结果显示,sh-ANRIL组PI3K、p-AKT、PCNA、BCL-2蛋白水平较sh-NC组显著降低,而BAX蛋白的表达增加。结论:ANRIL可能通过PI3K/AKT信号通路影响Kasumi-1细胞增殖和凋亡,ANRIL是AML的潜在治疗靶点。 Objective:To investigate the down-regulation of ANRIL(Antisense non-coding RNA in the INK4 Locus)effects on proliferation and apoptosis of Kasumi-1 cells and its related molecular mechanism.Methods:Recombinant lentivirus was used to construct ANRIL down-regulation Kasumi-1 cells(sh-ANRIL group)and its control cells(sh-NC group).A fluorescence microscope was used to observe the transfection efficiency,RT-qPCR was used to detect knockdown efficiency and ANRIL expression in PBMCs and MBMCs of patients with acute myeloid leukemia(AML).Proliferation and apoptosis of Kasumi-1 cells were assayed by CCK-8 method and flow cytometry.Western blot was employed to detect the expression of PI3K,AKT,p-AKT,and relevant protein after down-regulation of ANRIL in Kasumi-1 cells.Results:ANRIL overexpressed significantly in PBMCs and MBMCs of patients with AML,the transfection efficiency of recombinant lentivirus carrying sh-ANRIL and sh-NC on Kasumi-1 cells exceeded 90%,and the knockdown efficiency was 70%.When DNR was administrated for 24,48,and 72 hours,the cell inhibition rate of the sh-ANRIL group was(47.40±1.49)%,(69.11±0.51)%and(91.82±1.10)%,which were significantly higher than those of the sh-NC group,respectively(P<0.05).The apoptotic rate in the sh-ANRIL group was(10.29±0.58)%,which was significantly higher than(5.42±0.67)%of the sh-NC group(P<0.01).After DNR treatment for 24 hours,the apoptotic rate of the sh-ANRIL group was(54.41±1.69)%,which was significantly higher than(38.28±1.42)%of sh-NC group(P<0.001).Western blot revealed that the protein levels of PI3K,p-AKT,PCNA,and BCL-2 in the sh-ANRIL group were reduced significantly than those in the sh-NC group,while the BAX protein expression increased.Conclusion:ANRIL may affect the proliferation and apoptosis of Kasumi-1 cells through PI3K/AKT signaling pathway.ANRIL is a potential therapeutic target for AML.
作者 张成思 许建霞 邓发滑 胡华丽 王斯奇 黄海 韦四喜 ZHANG Cheng-Si;XU Jian-Xia;DENG Fa-Hua;HU Hua-Li;WANG Si-Qi;HUANG Hai;WEI Si-Xi(School of Clinical Laboratory Science,Guizhou Medical University;Guizhou Center for Disease Control and Prevention;Center for Clinical Laboratories,The Affiliated Hospital of Guizhou Medical University,Guiyang 550004,Guizhou Province,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2022年第4期984-989,共6页 Journal of Experimental Hematology
基金 国家自然科学基金(81660027,81960031) 贵州省科技厅基金[2018]5779-70 贵州省科技厅基金[2019]5610号 贵阳市科技计划项目筑科合同[20161001]021号。
关键词 ANRIL PI3K/AKT 增殖 凋亡 ANRIL PI3K/AKT proliferation apoptosis
  • 相关文献

参考文献1

二级参考文献60

  • 1[34]Settakorn J,Kaewpila N,Burns GF,Leong AS.FAT,E-cadherin,beta catenin,HER 2/neu,Ki67 immuno-expression,and histological grade in intrahepatic cholangiocarcinoma.J Clin Pathol 2005; 58:1249-1254
  • 2[35]Nonomura A,Ohta G,Nakanuma Y,Izumi R,Mizukami Y,Matsubara F,Hayashi M,Watanabe K,Takayanagi N.Simultaneous detection of epidermal growth factor receptor (EGF-R),epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method.Liver 1988; 8:157-166
  • 3[36]Park J,Tadlock L,Gores GJ,Patel T.Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line.Hepatology 1999; 30:1128-1133
  • 4[37]Isomoto H,Kobayashi S,Werneburg NW,Bronk SF,Guicciardi ME,Frank DA,Gores GJ.Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholangiocarcinoma cells.Hepatology 2005; 42:1329-1338
  • 5[38]Moss SF,Blaser MJ.Mechanisms of disease:Inflammation and the origins of cancer.Nat Clin Pract Oncol 2005; 2:90-97; quiz 1 p following 113
  • 6[39]Kobayashi S,Werneburg NW,Bronk SF,Kaufmann SH,Gores GJ.Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells.Gastroenterology 2005; 128:2054-2065
  • 7[40]Tannapfel A,Sommerer F,Benicke M,Katalinic A,Uhlmann D,Witzigmann H,Hauss J,Wittekind C.Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma.Gut 2003; 52:706-712
  • 8[41]Xia X,Francis H,Glaser S,Alpini G,LeSage G.Bile acid interactions with cholangiocytes.World J Gastroenterol 2006; 12:3553-3563
  • 9[42]Werneburg NW,Yoon JH,Higuchi H,Gores GJ.Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines.Am J Physiol Gastrointest Liver Physiol 2003; 285:G31-G36
  • 10[43]Yoon JH,Higuchi H,Werneburg NW,Kaufmann SH,Gores GJ.Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line.Gastroenterology 2002; 122:985-993

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部